Kwality Pharmaceuticals Limited announces Q2 FY2026 results and auditor change
Kwality Pharmaceuticals · Pharmaceuticals & Biotechnology
Key highlights
- Approved unaudited standalone and consolidated financial results for Q2 and half year ended Sept 30, 2026.
- Resignation of statutory auditors M/s Vijay Mehra & Co. effective Nov 12, 2026; no concerns raised.
- Appointment of M/s B S R & Co. LLP as new statutory auditors subject to shareholders' approval, tenure until next AGM.
Original filing
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Kwality Pharmaceuticals
- Acquisition / mergerNotableKwality Pharmaceuticals acquires 4 acres for manufacturing expansion in Amritsar
Other financial results filings this fortnight
- Financial resultsSubam PapersSubam Papers Limited approves unaudited financial results for Q2 and H1 2026
- Financial resultsKCP Sugar & Industries CorporationK.C.P. Sugar and Industries Corporation Ltd reports unaudited Q2 & H1 FY2026 results
- Financial resultsNCL IndustriesNCL Industries approves 130 MW power project phases II & III and seeks cement plant land
- Tierra Agrotech approves Sept 2026 quarter and half-year results; appoints two executives
- SEPC Limited reports unaudited results for quarter and half-year to September 30, 2026
- SEPC posts Q2 consolidated loss of Rs 5,854.02 lakhs after deferred tax charge-off
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.